Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer
Public ClinicalTrials.gov record NCT00112996. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prevention of Cisplatin- or Oxaliplatin-Induced Peripheral Neuropathy With Alpha-Lipoic Acid: A Placebo-Controlled Phase III Trial
Study identification
- NCT ID
- NCT00112996
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- M.D. Anderson Cancer Center
- Other
- Enrollment
- 244 participants
Conditions and interventions
Conditions
Interventions
- alpha-lipoic acid Drug
- placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2006
- Primary completion
- Mar 31, 2014
- Completion
- Mar 31, 2014
- Last update posted
- Apr 7, 2014
2007 – 2014
United States locations
- U.S. sites
- 13
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hembree Mercy Cancer Center at St. Edward Mercy Medical Center | Fort Smith | Arkansas | 72913 | — |
| Horizon Oncology Center | Lafayette | Indiana | 47905 | — |
| CCOP - Wichita | Wichita | Kansas | 67214-3882 | — |
| Cabrini Center for Cancer Care at Christus St. Frances Cabrini Hospital | Alexandria | Louisiana | 71301 | — |
| CCOP - Kalamazoo | Kalamazoo | Michigan | 49007-3731 | — |
| CCOP - Metro-Minnesota | Saint Louis Park | Minnesota | 55416 | — |
| Cancer Research for the Ozarks | Springfield | Missouri | 65804 | — |
| CCOP - Columbia River Oncology Program | Portland | Oregon | 97225 | — |
| CCOP - Main Line Health | Wynnewood | Pennsylvania | 19096 | — |
| CCOP - Greenville | Greenville | South Carolina | 29615 | — |
| University of Texas M.D. Anderson CCOP Research Base | Houston | Texas | 77030-4009 | — |
| CCOP - Scott and White Hospital | Temple | Texas | 76508 | — |
| Marshfield Clinic - Marshfield Center | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00112996, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2014 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00112996 live on ClinicalTrials.gov.